Commission Implementing Regulation (EU) 2025/1490 of 24 July 2025 amending Implementing Regulation (EU) No 564/2013 as regards the adaptation of fees to inflation

Implementing Regulation (EU) 2025/1490 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Regulation (EU) No 564/2013 is amended as follows: (1) Annexes I and II are amended in accordance with Annex I to this Regulation; (2) Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEX ISupplementary provisions

ANNEX I Annexes I and II of Regulation (EU) No 564/2013 are amended as follows: (1) in Annex I, Table 1 is replaced with the following: ‘Table 1 Standard fees General description of task; relevant provision in Regulation (EU) No 528/2012 Specific condition or task description Fee (EUR) Approval of an active substance; Article 7(2) Fee for the first product-type for which that active substance is approved 143 400 Additional fee per additional product-type 47 800 Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012 23 900 Fee for the amendment of an approval, other than the addition of a product-type 23 900 Renewal of an approval; Article 13(3) Fee for the first product-type for which renewal of that active substance is sought 17 925 Additional fee per additional product-type 1 793 Additional fee for the first product-type for which renewal of that active substance is sought in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 29 875 Additional fee per additional product-type in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 2 988 Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012 23 900 Inclusion in Annex I of an active substance; Article 28 Fee for the first inclusion in Annex I of an active substance 11 950 Fee for the amendment of an inclusion of an active substance in Annex I 2 390 Notification in accordance with Article 17(4) of Commission Delegated Regulation (EU) No 1062/2014 ( 1 ) Fee per substance/product-type combination. The fee for the notification shall be deducted from the subsequent application for approval 11 950 (2) in Annex II, Table 1 is replaced with the following: ‘Table 1 Standard fees General description of task; relevant provision in Regulation (EU) No 528/2012 Specific condition or task description Fee (EUR) Granting of Union authorisation, single product; Article 43(2) Fee per product not identical with (one of) the representative product(s) assessed for the purpose of the substance approval 95 600 Fee per product identical with (one of) the representative product(s) assessed for the purpose of the substance approval 47 800 Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required 47 800 Additional fee per product when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012 11 950 Granting of Union authorisation, biocidal product family; Article 43(2) Fee per family 179 250 Additional fee per family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required 71 700 Additional fee per family when the requested authorisation is provisional in accordance with Article 55(2) of Regulation (EU) No 528/2012 17 925 Notification to the Agency of an additional product within a biocidal product family; Article 17(6) Fee per additional product 2 390 Union authorisation of a same biocidal product; Article 17(7) Fee per product constituting a ‘same product’ within the meaning of Commission Implementing Regulation (EU) No 414/2013 ( 2 ) 2 390 Major change of an authorised product or product family; Article 50(2) Fee per application 47 800 Minor change of an authorised product or product family; Article 50(2) Fee per application 17 925 Administrative change of an authorised product or product family; Article 50(2) Fee per notification 2 390 Recommendation on the classification of a change of an authorised product or product family; Article 50(2) Fee per request in accordance with Commission Implementing Regulation (EU) No 354/2013 ( 3 ) If the recommendation is to classify the change as an administrative or minor change, the fee for the request shall be deducted from the subsequent application or notification in accordance with Implementing Regulation (EU) No 354/2013 2 390 Renewal of Union authorisation, single product; Article 45(3) Fee per product 5 975 Additional fee per product in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 17 925 Additional fee per product when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required 47 800 Renewal of Union authorisation, biocidal product family; Article 45(3) Fee per product family 8 963 Additional fee per product family in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 26 888 Additional fee per product family when comparative assessment in accordance with Article 23 of Regulation (EU) No 528/2012 is required 71 700 ( 1 ) Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 294, 10.10.2014, p. 1 , ELI: http://data.europa.eu/eli/reg_del/2014/1062/oj ).’ ( 2 ) Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 125, 7.5.2013, p. 4 ., ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj ). ( 3 ) Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 109, 19.4.2013, p. 4 , ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj ).’

ANNEX IISupplementary provisions

ANNEX II ‘ANNEX III Other fees General description of task; relevant provision in Regulation (EU) No 528/2012 Specific condition or task description Fee (EUR) Technical equivalence; Article 54(3) Fee, when difference between the active substance sources is limited to a change in manufacturing location, and application is based solely on analytical data 5 975 Fee, when difference between the active substance sources goes beyond a change in the manufacturing location, and application is based solely on analytical data 23 900 Fee when previous conditions are not met. 47 800 Annual fee for biocidal products authorised by the Union; Article 80(1)(a) Fee per Union authorisation of a biocidal product 11 950 Fee per Union authorisation of a biocidal product family 23 900 Mutual Recognition Submission fee; Article 80(1)(a) Fee per product or product family concerned by an application for mutual recognition, per Member State where mutual recognition is sought 837 Appeal; Article 77(1) Fee per appeal 2 988 Submission for inclusion in the list of relevant persons; Article 95 Fee per submission of a letter of access to a dossier already found complete by the Agency or an evaluating Competent Authority 2 390 Fee per submission of a letter of access to part of a dossier already found complete by the Agency or an evaluating Competent Authority, together with complementary data 23 900 Fee per submission of a new dossier 47 800 Requests under Article 66(4) submitted to the Agency Fee per item for which confidentiality is requested 1 195 ’

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview